These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3968640

  • 21. The renal response to ureteral obstruction.
    Wahlberg J.
    Scand J Urol Nephrol Suppl; 1983; 73():1-30. PubMed ID: 6577583
    [Abstract] [Full Text] [Related]

  • 22. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
    Thomas NJ, Carcillo JA, Herzer WA, Mi Z, Jackson EK.
    J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
    [Abstract] [Full Text] [Related]

  • 23. Effects of uninephrectomy on renal structural properties in spontaneously hypertensive rats.
    Kinuno H, Tomoda F, Koike T, Takata M, Inoue H.
    Clin Exp Pharmacol Physiol; 2005 Mar; 32(3):173-8. PubMed ID: 15743399
    [Abstract] [Full Text] [Related]

  • 24. Antagonism of Ca2+-induced constriction of isolated rabbit ear artery by nitrendipine in high K+- and/or norepinephrine-containing medium.
    Scriabine A, Johnson CE, Steinsland OS, Anderson CL.
    J Cardiovasc Pharmacol; 1984 Mar; 6 Suppl 7():S944-8. PubMed ID: 6085382
    [Abstract] [Full Text] [Related]

  • 25. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V, Donoso MV, Brown N, Fanjul R, López C, Fournier A, Huidobro-Toro JP.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [Abstract] [Full Text] [Related]

  • 26. Reversal of renal and smooth muscle actions of the thromboxane mimetic U-44069 by diltiazem.
    Loutzenhiser R, Epstein M, Horton C, Sonke P.
    Am J Physiol; 1986 Apr; 250(4 Pt 2):F619-26. PubMed ID: 3963201
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Differential effect of T-type voltage-gated Ca2+ channel disruption on renal plasma flow and glomerular filtration rate in vivo.
    Thuesen AD, Andersen H, Cardel M, Toft A, Walter S, Marcussen N, Jensen BL, Bie P, Hansen PB.
    Am J Physiol Renal Physiol; 2014 Aug 15; 307(4):F445-52. PubMed ID: 24966091
    [Abstract] [Full Text] [Related]

  • 36. Diltiazem and renal hemodynamics: implications for renal protection.
    Epstein M.
    J Cardiovasc Pharmacol; 1991 Aug 15; 18 Suppl 9():S21-5. PubMed ID: 1725538
    [Abstract] [Full Text] [Related]

  • 37. Calcium antagonists and the kidney: implications for renal protection.
    Epstein M.
    J Cardiovasc Pharmacol; 1991 Aug 15; 18 Suppl 10():S64-70. PubMed ID: 1725007
    [Abstract] [Full Text] [Related]

  • 38. Comparison of the effects of nifedipine and nisoldipine on coronary vasoconstriction in the Langendorff-perfused rat heart.
    Okada T, Izawa N, Nakamura T.
    J Cardiovasc Pharmacol; 2000 Jan 15; 35(1):145-9. PubMed ID: 10630745
    [Abstract] [Full Text] [Related]

  • 39. Renal vascular responses to high and low ionized calcium: influence of norepinephrine in the isolated perfused rat kidney.
    Kaufmann MA, Pargger H, Castelli I, Steiner LA, Drop LJ.
    J Trauma; 1996 Jan 15; 40(1):110-5. PubMed ID: 8576971
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.